Business, Presentation and Recent Accounting Pronouncements (Details) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2024
USD ($)
|
Jun. 11, 2024
shares
|
Jan. 31, 2024
performance_obligation
|
Sep. 30, 2024
USD ($)
shares
|
Mar. 31, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2024
USD ($)
shares
|
Sep. 30, 2023
USD ($)
|
Jun. 10, 2024
shares
|
May 01, 2024
shares
|
Dec. 31, 2023
USD ($)
shares
|
|
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Cash and cash equivalents | $ 5,637,019 | $ 5,637,019 | $ 2,454,684 | ||||||||
Short-Term Investments | 23,398,016 | 23,398,016 | 0 | ||||||||
Accumulated deficit | (139,158,620) | (139,158,620) | $ (146,976,855) | ||||||||
Number of performance obligations | performance_obligation | 1 | ||||||||||
Proceeds from collaborators | $ 16,000,000 | ||||||||||
In-Process R&D Impairment | $ 2,000,000 | $ 2,008,000 | $ 1,904,314 | $ 2,008,000 | $ 1,904,314 | ||||||
Reverse stock split, conversion ratio | 0.111111111111111 | ||||||||||
Common stock, shares authorized (in shares) | shares | 150,000,000 | 150,000,000 | 150,000,000 | 150,000,000 | 50,000,000 | ||||||
Common stock, shares, outstanding (in shares) | shares | 2,970,545 | 3,000,788 | 3,000,788 | 26,735,116 | 856,182 | ||||||
In Process Research and Development | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
In-Process R&D | $ 6,700,000 | $ 6,700,000 | $ 8,700,000 |
X | ||||||||||
- Definition Collaborative Arrangement, Number Of Performance Obligations No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Cash received from collaborators during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|